| BioVision |
4324-1000 |
Apo-SAA, human recombinant
|
1 mg |
|
|
| BioVision |
4324-50 |
Apo-SAA, human recombinant
|
50 μg |
|
|
| BioVision |
4324-10 |
Apo-SAA, human recombinant
|
10 μg |
|
|
| BioVision |
4309-50 |
NT-4, human recombinant
|
50 μg |
|
|
| BioVision |
4312-10 |
Osteoprotegerin (OPG), human recombinant
|
10 μg |
|
|
| BioVision |
4312-1000 |
Osteoprotegerin (OPG), human recombinant
|
1 mg |
|
|
| BioVision |
4312-50 |
Osteoprotegerin (OPG), human recombinant
|
50 μg |
|
|
| BioVision |
4318-10 |
sRANK Ligand, human recombinant
|
10 μg |
|
|
| BioVision |
4318-1000 |
sRANK Ligand, human recombinant
|
1 mg |
|
|
| BioVision |
4318-50 |
sRANK Ligand, human recombinant
|
50 μg |
|
|
| BioVision |
4321-1000 |
RANTES, human recombinant
|
1 mg |
|
|
| BioVision |
4321-100 |
RANTES, human recombinant
|
100 μg |
|
|
| BioVision |
4321-20 |
RANTES, human recombinant
|
20 μg |
|
|
| BioVision |
4322-1000 |
RANTES, murine recombinant
|
1 mg |
|
|
| BioVision |
4322-20 |
RANTES, murine recombinant
|
20 μg |
|
|
| BioVision |
4323-100 |
RANTES, rat recombinant
|
100μg |
|
|
| BioVision |
4323-1000 |
RANTES, rat recombinant
|
1 mg |
|
|
| BioVision |
4323-20 |
RANTES, rat recombinant
|
20μg |
|
|
| BioVision |
4304-1000 |
NGF-beta, murine recombinant
|
1 mg |
|
|
| BioVision |
4304-20 |
NGF-beta, murine recombinant
|
20 μg |
|
|
| BioVision |
4304-5 |
NGF-beta, murine recombinant
|
5 μg |
|
|
| BioVision |
4306-10 |
NT-3, human recombinant
|
10 μg |
|
|
| BioVision |
4306-1000 |
NT-3, human recombinant
|
1 mg |
|
|
| BioVision |
4306-50 |
NT-3, human recombinant
|
50 μg |
|
|
| BioVision |
4307-10 |
NT-3, murine recombinant
|
10 μg |
|
|
| BioVision |
4307-50 |
NT-3, murine recombinant
|
50 μg |
|
|
| BioVision |
4307-1000 |
NT-3, murine recombinant
|
1 mg |
|
|
| BioVision |
4309-10 |
NT-4, human recombinant
|
10 μg |
|
|
| BioVision |
4309-1000 |
NT-4, human recombinant
|
1 mg |
|
|
| BioVision |
4276-10 |
CCL23/Ck beta 8-1, human recombinant
|
10 μg |
|
|
| BioVision |
4276-50 |
CCL23/Ck beta 8-1, human recombinant
|
50 μg |
|
|
| BioVision |
4276-1000 |
CCL23/Ck beta 8-1, human recombinant
|
1 mg |
|
|
| BioVision |
4277-10 |
CXCL10/IP-10/CRG-2, human recombinant
|
10 μg |
|
|
| BioVision |
4277-50 |
CXCL10/IP-10/CRG-2, human recombinant
|
50 μg |
|
|
| BioVision |
4277-1000 |
CXCL10/IP-10/CRG-2, human recombinant
|
1 mg |
|
|
| BioVision |
4278-10 |
CXCL14/BRAK, human recombinant
|
10 μg |
|
|
| BioVision |
4278-50 |
CXCL14/BRAK, human recombinant
|
50 μg |
|
|
| BioVision |
4278-1000 |
CXCL14/BRAK, human recombinant
|
1 mg |
|
|
| BioVision |
4279-10 |
Granzyme A, human recombinant
|
10 μg |
|
|
| BioVision |
4279-50 |
Granzyme A, human recombinant
|
50 μg |
|
|
| BioVision |
4279-1000 |
Granzyme A, human recombinant
|
1 mg |
|
|
| BioVision |
4303-1000 |
NGF-beta, human recombinant
|
1 mg |
|
|
| BioVision |
4303-20 |
NGF-beta, human recombinant
|
20 μg |
|
|
| BioVision |
4303R-100 |
NGF-beta, human recombinant
|
100 μg |
|
|
| BioVision |
4303R-1000 |
NGF-beta, human recombinant
|
1 mg |
|
|
| BioVision |
4303R-20 |
NGF-beta, human recombinant
|
20 μg |
|
|
| BioVision |
4304-100 |
NGF-beta, murine recombinant
|
100 μg |
|
|
| BioVision |
4275-50 |
CCL14/HCC-1/HCC-3, human recombinant
|
50 μg |
|
|
| BioVision |
4275-1000 |
CCL14/HCC-1/HCC-3, human recombinant
|
1 mg |
|
|
| BioVision |
4267-10 |
HB-EGF, mouse recombinant
|
10 μg |
|
|